title: Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.
authors.affiliation: Finnish Red Cross Blood, Helsinki, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Pakkala
authors.forename: K
authors.initials: K
authors.lastname: Salmela
authors.forename: I
authors.initials: I
authors.lastname: Lautenschlager
authors.forename: J
authors.initials: J
authors.lastname: Ahonen
authors.forename: P
authors.initials: P
authors.lastname: Häyry
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000517:prevention & control*
chemical_list: D000961:Antilymphocyte Serum